
Moderna Inc. has said it will apply for US and European emergency authorisation of its COVID-19 vaccine on Monday based on full results from a late-stage study showing its vaccine was 100 percent effective in preventing severe cases and 94.1 percent on the regular. The filing sets Moderna’s product up to be the second vaccine…
This content is for
- Standard Bi-Annual, Premium Bi-Annual, Standard Yearly, Premium Yearly, Staff, 2 Weeks FREE plan, Standard Bi-Annual USD, Standard Yearly USD, Premium Bi-Annual USD, Premium Yearly USD, BusinessDay/Ready Set Work Premium Yearly (FREE), 2 Weeks FREE plan (Flutterwave), 2 Weeks FREE plan (Paylater), 2 Weeks FREE plan (Union Bank), 2 Weeks FREE plan (NAIJASTARTUP), Premium Yearly (Union Bank), 2 Weeks FREE plan (She Leads Africa), 2 Weeks FREE plan (PiggyVest), Combo offer with print, 2 Weeks FREE plan (Wema Bank), Standard Yearly- Welcome Back Package, Premium Yearly (CFA Society Nigeria ), Monthly Plan , USD monthly, Campus/Student Plan, $3.99 for 2 months, 1 Month Free , N500 for 1 month**, Standard Monthly, Test Free Card, Delay Sub testing, Test Free Trial, Student Yearly, Premium Monthly, 14 Days Free Trial, 30 Days Free Trial, and TEST paystack
members only. Visit the site and log in/register to read.
MORE NEWS SOURCES FROM OTHER NEWSPAPERS ON THIS TOPIC:
- NAFDAC safety test approval not for efficacy of product -DG ABUJA – The National Agency for Foods and Drugs Administration and Control (NAFDAC) safety test approval is not a stamp for verifying the efficacy of the producers claims. Prof. Mojisola…
- Moderna: Patent ruling won’t affect COVID-19 vaccine… Moderna Inc said on Friday its formula used in developing a COVID-19 vaccine was not covered under patents owned by Arbutus Biopharma. An administrative court run by the…
- Moderna’s COVID-19 vaccine worked well in monkeys ― Study US biotech firm Moderna’s COVID-19 vaccine induced a robust immune response and prevented the coronavirus from replicating in the noses and lungs of monkeys, a study in the New England…
- Moderna vaccine protects against COVID-19 in monkey study Moderna Inc on Tuesday said its experimental COVID-19 vaccine induced a robust immune response and protected against infection in a study on monkeys. The vaccine, MRNA-1273, given to non-human…
- Moderna says test data shows vaccine is well… The US Bio-tech firm Moderna’s experimental coronavirus vaccine appears to be safe and elicits an immune response in all age groups, including the elderly, a company official said Wednesday in…
- Moderna: Covid vaccine shows nearly 95% protection A new vaccine that protects against Covid-19 is nearly 95% effective, early data from US company Moderna shows. The results come hot on the heels of similar results from…
- India records 100,000 coronavirus cases in 6 days,… The death toll from the novel coronavirus pandemic in India has surpassed 20,000 amid huge daily spikes in infections as the country introduces further relaxations to its protracted lockdown. “A…
- U.S. expects approval of Covid-19 vaccine December The US health secretary, Alex Azar, said on Tuesday morning that America hopes to have a coronavirus vaccine approved by December and tamped down Russia’s celebrations over unveiling its own…
- Bill Gates touts Pfizer’s vaccine as most likely to… Bill Gates Bill Gates says Pfizer has the best chance of seeking emergency approval for a coronavirus vaccine by next month even though he thinks such an aggressive timeline is…
- China tests Nasal covid vaccine as WHO praises halt… China on Wednesday approved phase I human testing for the nasal spray vaccine, which is co-developed by researchers at Xiamen University and Hong Kong University, as well as by vaccine…
- Trump says US will purchase 100 million doses of… U.S. President Donald Trump wears a mask while visiting Walter Reed National Military Medical Center in Bethesda, Maryland, U.S., July 11, 2020. PHOTO: Reuters President Donald Trump on Tuesday said…
- De Gea should save Chelsea’s second goal 100 times… Manchester United’s David de Gea should save Chelsea’s second goal “100 times out of 100,” according to manager Ole Gunnar Solskjaer after errors by the hapless goalkeeper saw his side…
- Tony Elumelu named in ‘TIME 100’ list of 100 most… TIME has named Tony O. Elumelu, one of Africa’s leading investors and philanthropists, in the 2020 TIME100, the annual list of the 100 most influential people in the world. The…
Find more latest news and headlines from the newspaper